Expression of Interest for C-CAMP Netherlands Global Innovation Catapult

The C-CAMP Netherlands Global Innovation Catapult is a strategic market-access initiative launched by the Centre for Cellular and Molecular Platforms (C-CAMP) in partnership with the Netherlands Embassy in India and Invest in Holland. This program is designed specifically for Indian health tech companies that are ready to scale and expand internationally. It serves as a bridge between Indian innovation and the advanced Dutch healthcare system, focusing on technologies that can address critical needs such as reducing healthcare worker workload, improving operational efficiency, enabling remote and home-based care, promoting patient independence, and automating routine tasks. Selected companies will gain unparalleled access to the Dutch health ecosystem, including regulatory insights, stakeholder connections, and market validation opportunities, paving the way for expansion into the Netherlands and the broader European Union. This collaboration underscores the commitment of both countries to foster cross-border healthcare innovation.

• Facilitated entry into the Dutch healthcare ecosystem
• Targets Indian health tech companies at commercial stage
• Focus on automation, efficiency, remote care technologies
• CE certification preferred
• Networking with Dutch Ministry of Health (VWS) and NFIA
• No cash grant; market access and regulatory support offered

Indian health tech companies at a commercial stage are invited to apply. This includes businesses that are scaling up, already generating revenue, or actively deploying their solutions in pilots or real-world settings. Priority is given to technologies that address specific Dutch healthcare challenges: reducing employee workload (e.g., automated vitals monitoring, AI diagnostics), enhancing operational efficiency (e.g., smart wards, AI assistants), expanding care to non-hospital settings (e.g., wearable biosensors, remote monitoring), promoting patient self-sufficiency (e.g., portable heart monitors, at-home rehabilitation), and optimizing tasks through automation (e.g., neonatal therapy, automated medicine dispensaries). Companies that already possess CE certification or have a clear, near-term pathway to obtaining it will receive preference during evaluation.

Expression of Interest for C-CAMP Netherlands Global Innovation Catapult is open to startups at any stage. It is open to startups registered anywhere in India.

The most recent application window for Expression of Interest for C-CAMP Netherlands Global Innovation Catapult closed on 5 Jul 2026. Many programmes run repeat cohorts, so it is worth checking the official site for the next round.

This program does not provide direct cash grants or equity investments. Instead, it offers comprehensive market-access and soft-landing support tailored for Indian health tech innovators. Selected companies will receive:

• Expert knowledge and regulatory guidance specific to the Dutch healthcare landscape, including insights into market dynamics, regulatory pathways, and best practices.
• A round table service conducted by the Dutch Ministry of Health, Welfare and Sport (VWS) through HI-NL, providing early-stage advice on market entry strategies and stakeholder expectations.
• Direct meetings and networking opportunities with key Dutch healthcare stakeholders, including hospitals, insurance companies, and government agencies, organized by the Netherlands Foreign Investment Agency (NFIA). This support is designed to validate the innovation, establish strategic partnerships, and facilitate successful market entry and expansion into the Netherlands and the wider EU.

Expression of Interest for C-CAMP Netherlands Global Innovation Catapult is offered by Centre for Cellular and Molecular Platforms (C-CAMP), a startup incubator. It is delivered directly by Centre for Cellular and Molecular Platforms (C-CAMP) as a grant. You can verify current details and timelines on the provider's official website before applying.

Applications submitted via the Expression of Interest (EOI) form are first screened by C-CAMP and its partners based on technological innovation, alignment with program focus areas, commercial maturity (scaling, revenue-generating, or piloting), and regulatory preparedness, with a strong preference for CE certification or a clear pathway. Shortlisted companies are then invited to in-person meetings where a selection committee—comprising representatives from C-CAMP, the Health Team of the Netherlands Embassy, the Netherlands Foreign Investment Agency (NFIA), and Dutch healthcare experts—evaluates the company's value proposition, market fit, and team capability. The final decision selects five companies with the highest strategic fit and potential for success, who will then proceed to the facilitated market-access visit.

Before you apply to Expression of Interest for C-CAMP Netherlands Global Innovation Catapult, keep the following documents ready:

• A pitch deck or short business plan describing the problem, product and traction
• Company registration documents and PAN
• Founder identification (PAN / Aadhaar) and brief profiles
• Recent financial statements or projections
• Product details — a demo, prototype or working link if available

Exact requirements are confirmed on the official application portal — treat this as a preparation checklist.